首页> 外国专利> Composition and a diagnostic method for the detection of prostatic cancer.

Composition and a diagnostic method for the detection of prostatic cancer.

机译:用于检测前列腺癌的组合物和诊断方法。

摘要

A kind of immunochemistry detection method detection prostatic acid phosphatase, which has, to be developed, these can be used for enzyme and protein determination in prostate cancer and clinical trial test. It is carcinous from human prostate tissue that a kind of prostatic acid phosphatase isoenzymatically homogeneously prepares antigen isolation purified acid phosphatase. The stimulation of the antigen generates diagnostic antibody, and which is high special, and there is no cross reactions, and can be used for other acid phosphatase isoenzyme counter immunoelectrophoresis technologies and (show 0.4 I.U.Sensitivity or 20 enzymatic activitys reach enzymic protein) and solid phase fluorescent immune (show the excitation of 60 mcg/ml enzymic protein of sensitivity and alpha-Naphthol hydrolysate and emit at 340 nanometers 465 nanometers) lack, without false positive and false negative diagnosis of prostate cancer.
机译:一种正在开发的可检测前列腺酸磷酸酶的免疫化学检测方法,可用于前列腺癌的酶和蛋白质测定以及临床试验。从人的前列腺组织中可知,一种前列腺酸磷酸酶同功酶联地制备抗原分离纯化的酸性磷酸酶。抗原的刺激产生诊断性抗体,具有很高的专一性,并且没有交叉反应,可用于其他酸性磷酸酶同工酶反免疫电泳技术,并且(显示0.4 IUSensitivity或20种酶活性达到酶蛋白)和固体缺乏阶段性荧光免疫(显示出60 mcg / ml的激发性敏感性酶蛋白和α-萘酚水解物的激发,并在340纳米和465纳米处发射),没有对前列腺癌的假阳性和假阴性诊断。

著录项

  • 公开/公告号EP0018967A4

    专利类型

  • 公开/公告日1980-09-29

    原文格式PDF

  • 申请/专利权人 RESEARCH CORPORATION;

    申请/专利号EP19790900093

  • 发明设计人 WANG MING CHANG;CHU TSANN MING;

    申请日1979-07-31

  • 分类号C07G7/00;C12N9/14;C12Q1/42;

  • 国家 EP

  • 入库时间 2022-08-22 17:56:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号